Essential Partners »

Akebia Therapeutics shares owned by Essential Partners

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Essential Partners from 13F filings

Historical chart of Essential Partners investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Essential Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Essential Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.8k 3.4k 1.14
2026-03-31 $853 614 1.39
2025-09-30 $1.5k 550 2.73
2025-06-30 $2.0k 537 3.64

More positions owned by Essential Partners

Sprott Gold Convert to Physical Cef (PHYS)
Vanguard Short-Term USTS Etf (VGSH)
iShares S&P 500 Etf (IVV)
Schwab Fundamental Int'l Broad Etf (FNDF)
Schwab Fundamental U.S. Broad Etf (FNDB)
iShares 0-3 Month T-Bills ETF Etf (SGOV)
iShares Core MSCI Emerging Markets Etf (IEMG)
iShares MSCI Emerging Markets Ex-China Etf (EMXC)
Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
GMO US Value Etf (GMOV)
Micron Technology Stock (MU)
Comfort Sys Usa Stock (FIX)
Energy ETF Etf (XLE)
Schwab International Etf (SCHF)

View all positions for Essential Partners

Top funds holding Akebia Therapeutics

BlackRock
State Street Corporation
Vanguard Capital Management
AQR Capital Management
Geode Capital Management
Jacobs Levy Equity Management
Acadian Asset Management
Goldman Sachs Group
Millennium Management
Citigroup
Vanguard Portfolio Management
Two Sigma Investments
Charles Schwab Investment Management
Sixth Street Partners Management Company
Northern Trust

View all funds holding Akebia Therapeutics